Grace F. Barker

Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype

A. Darzi, H. Ashrafian, T. Athanasiou, 2021, Microbiome.

Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites

E. Holmes, J. Marchesi, M. Thursz, 2020, Gut microbes.

Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.

C. Kelly, J. Marchesi, B. Mullish, 2020, Inflammatory bowel diseases.

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection

Thomas B. Clarke, E. Holmes, J. Marchesi, 2019, Gut.

Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype

A. Darzi, H. Ashrafian, T. Athanasiou, 2021, Microbiome.

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.

I. García-Pérez, J. Marchesi, K. Kennedy, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and disease.

J. Marchesi, M. Thursz, B. Mullish, 2018, Methods.

7 – The Icon Study: Inflammatory Bowel Disease and Recurrent Clostridium Difficile Infection: Outcomes After Fecal Microbiota Transplantation

C. Kelly, J. Marchesi, B. Mullish, 2019, Gastroenterology.

Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and disease.

J. Marchesi, M. Thursz, B. Mullish, 2018, Methods.